Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-05-26
1999-01-26
Teng, Sally P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530350, 530395, 530399, 435691, C07K 14705
Patent
active
058638881
ABSTRACT:
The complete cDNA cloning of two human genes previously designated flg and bek is disclosed. These genes encode for two similar but distinct surface receptors comprised of an extracellular domain with three immunoglobulin-like regions, a single transmembrane domain, and a cytoplasmic portion containing a tyrosine kinase domain with a typical kinase insert. The expression of these two cDNAs in transfected NIH-3T3 cells led to the biosynthesis of proteins of 150 kDa and 135 kDa for flg and bek respectively. Direct binding experiments with radiolabeled acidic FGF (aFGF), basic FGF (bFGF), or kFGF inhibition of binding with native growth factors, and Scatchard analysis of the binding data indicated that bek and flg bind aFGF, bFGF, or kFGF with dissociation constants of (2-15).times.10.sup.-11 M. The high affinity binding of three distinct growth factors to each of two different receptors represents a unique double redundancy without precedence among polypeptide growth factor/receptor interactions. The use of transformed host cells overexpressing fig or bek or biologically active fragments thereof for drug screening is disclosed.
REFERENCES:
J. Biol. Chem. 260: 13860-13868, 1985, Neufeld Gospodarowicz, English Original.
J. Biol. Chem. 263: 14023-14029, 1988, Feige Baird English Original.
Biochem. Biophys. Res. Commun. 155: 583-590, 1988, Imamura Tokita Mitsui, English Original.
Molec. and Cell. Biol. 8: 5541-5544, 1988, Kornbluth Paulson Hanafusa, English Original.
Oncogene 3: 9-15, 1988, Ruta Howk Ricca, Drohan Zabelshansky et al., English Original.
J. Biol. Chem. 264: 18647-18653, 1989, Burrus Olwin, English Original.
Science 245: 57-60, 1989, Lee Johnson Cousens, Fried Williams, English Original.
Proc. Natl. Acad. Sci. USA 86: 5449-5453, 1989, Pasquale singer, English Original.
Proc. Natl. Acad. Sci. USA 86: 8722-8726, 1989, Ruta Burgess Givol, Epstein Neiger et al., English Original.
Nucleic Acids Res. 18: 1906, 1990, Isacchi Bergonzoni Sarmientos, English Original.
Science 248: 1410-1413, 1990, Kaner Baird Mansukhani, Basilico Summers et al., English Original.
Proc. Natl. Acad. Sci. USA 87: 1596-1600, 1990, Reid Wilks Bernard, English Original.
Cold Spring Harbor Laboratory, 1982, Maniatis et al., English Original.
Green Publishing Assoc. and Wiley Interscience, 1987, Ausubel, et al., eds., English Original.
Biochem. Biophys. Res. Commun. 169: 680-685, 1990, Itoh Terachi Ohta, Seo, English Original.
Molec. Cell. Biol. 11:4627-4634, Sep. 1991, Johnson Lu Chen, Werner Williams, English Original.
Growth Factors 5:115-127, 1991, Kiefer Baird Nguyen, George-Nascime Mason et al., English Original.
Molec. Cell. Biol. 11:5068-5078, 1993, Mohammadi Honegger Rotin, Fischer Bellot et al., English Original.
WO 91/00916, Jul. 6, 1990, Jan. 24, 1991, Williams Johnson Lee, English Original.
Sambrook et al., Molecular Cloning, A lab. Manual, Second Edition, vol. 3, pp. 16.2-16.30 and 71.2-17.28, 1989 Cold Spring Harbor Lab. Press, Cold Spring Harbor.
Duan et al., J. of Biol. Chem., 266, 413-418, 1991.
Crumley Gregg B.
Dionne Craig A.
Jaye Michael C.
Schlessinger Joseph
Rhone-Poulenc Rorer Pharmaceuticals Inc.
Teng Sally P.
LandOfFree
Human Bek Fibroblast growth factor receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human Bek Fibroblast growth factor receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human Bek Fibroblast growth factor receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1450433